14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
VCIG vs CDT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, VCI Global Limited Ordinary Share (VCIG) is the stronger overall head-to-head candidate over CDT Equity Inc. (CDT) in the Tradestie Institutional Equity Comparison Engine, winning 3–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, Options & Positioning). VCIG carries a Unified Composite Score of 35.1/100 (SELL) at $2.66 (N/M Forward P/E, -444.5% operating margin), whereas CDT carries 31.6/100 (SELL) at $0.23 (N/M Forward P/E, 0.0% operating margin).
Growth vs. Quality Trade-Off: VCIG earns the overall head-to-head edge with a stronger Unified Composite Score (35.1/100 SELL vs. CDT 31.6/100 SELL) and -16.05β · 16019% Vol risk profile, whereas CDT leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Defensive Composite Rating Caution: Although VCIG compares more favorably head-to-head, both VCIG (35.1/100 SELL) and CDT (31.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: VCIG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.0); meanwhile CDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on VCIG vs CDT. Trailing 12-month operating profitability (VCIG -444.5% vs CDT 0.0%) and valuation multiples (VCIG N/M vs CDT N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Biotechnology value chain with $507,528 market capitalization and 0.0% operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ VCIG vs CDT Key Questions & Quantitative Answers
As of Nov 20, 2026, VCI Global Limited Ordinary Share (VCIG) is the stronger overall head-to-head candidate over CDT Equity Inc. (CDT) in the Tradestie Institutional Equity Comparison Engine, winning 3–3 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Balance Sheet & Cash Flow, Options & Positioning). VCIG carries a Unified Composite Score of 35.1/100 (SELL) at $2.66 (N/M Forward P/E, -444.5% operating margin), whereas CDT carries 31.6/100 (SELL) at $0.23 (N/M Forward P/E, 0.0% operating margin). Growth vs. Quality Trade-Off: VCIG earns the overall head-to-head edge with a stronger Unified Composite Score (35.1/100 SELL vs. CDT 31.6/100 SELL) and -16.05β · 16019% Vol risk profile, whereas CDT leads top-line expansion (+0.0% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although VCIG compares more favorably head-to-head, both VCIG (35.1/100 SELL) and CDT (31.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: VCIG trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 47.0); meanwhile CDT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 44.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
CDT leads the Growth & Scale pillar: VCIG posts -86.4% YoY revenue growth and -83.8% YoY earnings growth on $9.9M TTM revenue (N/A gross margin, -444.5% operating margin), compared with CDT at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, VCIG generates $9.9M in USD-normalized revenue versus N/A for CDT. In operating R&D and SG&A reinvestment, VCIG deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CDT.
VCIG screens cheaper on headline valuation multiples. VCIG trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.2x EV/Revenue (unreported EBITDA margin), whereas CDT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against VCIG (-31.1% ROE) versus CDT (-69.7% ROE) capital efficiency.
In options market volatility and institutional positioning, VCIG carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-16.05β · 16019% Vol realized risk). By comparison, CDT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (-17.75β · 10175% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.